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Aim To determine the reasons for large standard deviation of 
bronchodilator response (BDR) and establish whether there 
is a potential heritable component in healthy subjects.
Methods 67 monozygotic and 42 dizygotic adult twin 
pairs were assessed for bronchodilator response (% change 
in FEV1 after inhaling 400 µg salbutamol). Univariate quan-
titative genetic modeling was performed.
Results Multiple regression modeling showed a signifi-
cant association between BDR and sex and baseline FEV1 
(P < 0.05), while no association was found with smoking 
habits, body mass index, or age. Within pair correlation in 
monozygotic twins was modest (0.332), but higher than 
in dizygotic twins (0.258). Age-, sex-, and baseline FEV1-
adjusted genetic effect accounted for 14.9% (95% con-
fidence interval, CI 0%-53.1%) of the variance of BDR, 
shared environmental effect for 18.4% (95% CI 0%-46.8%), 
and unshared environmental effect for 66.8% (95% CI 
46.8%-88.7%).
Conclusion Our twin study showed that individual differ-
ences in BDR can be mostly explained by unshared envi-
ronmental effects. In addition, it is the first study to show 
low, insignificant hereditary influences, independently 
from sex, age, and baseline FEV1.
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The assessment of the reversibility of airway obstruction is 
a key element in the diagnosis of airway diseases and can 
also be a sign of the potential therapeutic effect of a specific 
inhaled drug (1,2). Bronchodilator response (BDR) is tested 
after the inhalation of a drug and is defined as the change in 
spirometric parameters including forced vital capacity (FVC), 
forced expiratory volume in 1 second (FEV1), and mid-expira-
tory flow 25%-75%. Although no consensus exists, the latest 
American Thoracic Society (ATS)/European Respiratory Soci-
ety (ERS) guideline recommends that, during a single testing 
session, an increase in FEV1 or FVC>12% and ≥200 mL from 
baseline is considered a significant BDR (3).
Large population studies proposed a different threshold of 
BDR that has a role in clinical interpretation of airway re-
sponse to a bronchodilator (4,5). However, underlying rea-
sons for the large variation of BDR and a potential herita-
ble component in healthy population are still unclear. It is 
known that certain genetic polymorphisms are associated 
with BDR in asthmatic (6,7) and non-asthmatic (8,9) indi-
viduals. This is supported by the fact that there are differ-
ences in BDR among different nations (10). These studies 
strongly support a hereditary influence on BDR, but they 
cannot fully describe the relationship of hereditary and en-
vironmental factors on the development of BDR. Assessing 
familial aggregation of BDR, Niu et al found a modest famil-
ial clustering (11).
Family design can determine inter-generation resemblance 
or difference, but, in contrast to the twin study design, it does 
not determine the influence of outside factors such as fam-
ily, environment, and culture (12). Accordingly, family stud-
ies cannot reliably distinguish the influence of heritability 
from common environmental effects. Numerous twin stud-
ies examined airway hyperresponsiveness (AHR) (13-18), but 
none of them investigated BDR. Although BDR is usually as-
sociated with AHR in obstructive airway diseases (19), previ-
ous twin results on AHR cannot simply be extended to BDR. 
Therefore, the first aim of this study is to determine which 
factors affect BDR in a healthy twin population. As a second 
aim we investigated whether the large standard deviation of 
BDR in healthy asymptomatic subjects could be attributable 
to genetic or environmental factors.
PArTICIPAnTS AnD METHoDS
Participants
One hundred and nine adult twin pairs (67 monozygotic 
[MZ] and 42 dizygotic [DZ]) were recruited from the Hun-
garian Twin Registry (20) as part of the International Twin 
Study 2009. Zygosity was assessed using a standard vali-
dated questionnaire concerning the degree of physical 
similarity of twins during infancy. Zygosity determination 
through this method is >99% accurate (21). The study pro-
tocols were approved by the institutional review board for 
human studies of Semmelweis University, Budapest, Hun-
gary (Regional and Institutional Committee of Science and 
Research Ethics, 29/2009) and written consent was ob-
tained from each participant or their surrogate.
Study design
Participants were recruited from general population via 
email, telephone, mail, or during twin festivals. Exclusion 
criteria included pregnancy, acute respiratory infection 
within three weeks of measurement, chronic obstructive 
airway diseases including asthma and chronic obstructive 
pulmonary disease (COPD), or foreseeable lack of compli-
ance with test procedures. Participants were tested in two 
large hospitals in Budapest, Hungary by the same trained 
personnel (DLT, ADT). Prior to testing, they were asked to 
refrain from smoking for at least 3 hours, drinking alcohol 
or coffee for 10 hours, and eating for 1 hour.
Baseline lung function measurement
Lung function was assessed by dynamic spirometry 
(Minispir, Waukesha, WI, USA). The spirometer was calibrat-
ed daily using a 1-L syringe. FEV
1 measurements were per-
formed in accordance with guidelines of the American Tho-
racic Society/European Respiratory Society Task Force (22).
Bronchodilator response
Following the baseline lung function assessment, all par-
ticipants inhaled 400 µg salbutamol in line with the ATS/
ERS guidelines (22). BDR was assessed by bronchodilator 
response (change in FEV1 after inhaling 400 µg salbuta-
mol). Salbutamol was inhaled from a metered dose inhaler 
without a spacer device and post- bronchodilator spirom-
etry was recorded after 15 minutes. Bronchial reversibility 
was considered if the increase in FEV1 was at least 12% and 
200 mL (23). No side effects were observed following the 
BDR tests.
Statistical analysis
Descriptive statistics (mean ± standard deviation for 
continuous variables, percentage for categorical 
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variables) were computed for MZ and DZ twins separately. 
MZ and DZ subsamples were compared by t test for paired 
samples. Multiple regression analysis identified potential 
variables associated with BDR, which were included as co-
variates in subsequent twin structural equation models. 
Regression analysis used robust estimation of standard er-
rors to adjust for the clustering of data between twin and 
co-twin within pair.
Twin resemblance within MZ and DZ pairs was evaluat-
ed using Pearson correlation coefficients obtained with 
a saturated model in the Mx software (24); the saturated 
model was specified by constraining means and varianc-
es to be the same for twin and co-twin, and for MZ and 
DZ twins. A higher correlation in MZ than in DZ pairs sug-
gests a contribution of genetic factors to the phenotype, 
similar correlation in MZ and DZ pairs suggests a contri-
bution of shared environmental factors, while low correla-
tion in MZ pairs compared to DZ twins suggests a contri-
bution of unshared environmental factors. In particular, the 
genetic component is approximated by twice the differ-
ence between MZ and DZ correlation (2(MZ-DZ)) and the 
unshared environmental component is approximated by 
1-MZ correlation (24,25).
Biometric univariate structural equation models were fitted 
to estimate the relative importance of hereditary and envi-
ronmental effects on percent variation in FEV1 values (us-
ing the % change in FEV1 as a continuous variable) (24,26). 
These models incorporate latent variables for genetic and 
environmental influence and observed variables for mea-
sured FEV1 change in twins. The effect of latent variables 
on observed variables is inferred from the observed vari-
ances and covariances by exploiting the fact that MZ twins 
share 100% of their genes, while DZ twins share 50% of the 
genetic background. Twin models assume that relevant 
environmental exposures are shared by the twins to the 
same extent regardless of zygosity (“equal environments 
assumption”) (24).
Using these models, it is possible to decompose the phe-
notypic variance of BDR into additive genetic (A), shared 
environmental (C), and unshared environmental (E) com-
ponents (ACE model). Shared environment includes those 
factors that are not related to individual lifestyle, such as 
familiar socialization, air pollution, shared womb, while 
unique environment includes smoking or nutrition. All 
twin analyses were adjusted by age, sex, and baseline 
FEV1. The analyses were carried out with Stata (version 
11.0, StataCorp, College Station, TX, USA) and Mx softwares 
(Department of Psychiatry Virginia Institute for Psychiatric 
and Behavioral Genetics, Richmond, VA, USA) (27). The level 
of statistical significance was set at P < 0.05.
rESuLTS
61.5% of twins were MZ and 38.5% were DZ (72% wom-
en) (Table 1). No significant difference between the groups 
was observed in age, body mass index, and smoking prev-
alence. DZ twins had higher FEV1 change compared to MZ 
twins, although the difference was not significant (3.4 ± 6.5 
vs 2.0 ± 5.5%, P = 0.278). 11 participants had a positive BDR 
test. Although BDR (FEV1 change) showed no correlation 
with baseline FVC (L) (P > 0.05), a significant but weak in-
TABLE 1. Characteristics of twins according to zygosity. Data reported as mean ± standard deviation or n (%)*
Total Monozygotic Dizygotic P
Twin subjects, n (%) 218 134 (61.5) 84 (38.5) -
Male, n (%)  61 (28.0)  32 (23.9) 29 (34.5) 0.550
Age, years 44.7 ± 15.6 44.3 ± 15.9 45.4 ± 15.2 0.788
Body mass index, kg/m2 25.8 ± 4.9 25.5 ± 4.9 26.3 ± 4.9 0.361
Never smokers, n (%) 149 (69.0)  95 (72.0) 54 (64.3)
0.354Past smokers, n (%)  31 (14.3)  16 (12.1) 15 (17.9)
Current smokers, n (%)  36 (16.7)  21 (15.9) 15 (17.9)
Positive BDR test, n (%)†  11 (5.1)   4 (3.0)  7 (8.3) 0.430
FVC, l  3.6 ± 0.9  3.4 ± 0.9  3.8 ± 1.0
FVC, % predicted  3.7 ± 0.9  3.6 ± 0.8  3.8 ± 1.0 0.124
FEV1, l  3.0 ± 0.8  2.9 ± 0.7  3.1 ± 0.8 0.156
FEV1, % predicted  3.1 ± 0.8  3.0 ± 0.7  3.2 ± 0.8 0.067
FEV1/FVC  0.84 ± 0.08  0.82 ± 0.11  0.83 ± 0.09 0.767
Mean FEV1% change  2.5 ± 6.0  2.0 ± 5.5  3.4 ± 6.5 0.278
*BDr – bronchodilator response; FVC – forced vital capacity; FEV1 – forced exhaled volume in one second.
†defined as 12% and 200 mL increase in FEV1 following 400 µg salbutamol.
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verse correlation was noted with FEV1/FVC (r = -0.20, 
P < 0.001). Participants with FEV1/FVC<0.70 (n = 13) showed 
a greater BDR response than participants with FEV1/FVC > 
0.70 (8.6 vs 2.0, P < 0.01).
In multiple robust regression analysis, smoking status, body 
mass index, and age were not significantly associated with 
BDR. Biometric models were adjusted for age as well as for 
variables that were associated with FEV1 change in the re-
gression model (ie, sex and baseline FEV1) (Table 2).
Intraclass correlation of percent change in FEV1 was mod-
est but higher in MZ twins (rMZ = 0.332, 95% CI 0.083, 
0.532) than in DZ twins (rDZ = 0.258, 95% CI -0.041, 0.499), 
suggesting a weak genetic effect in the expression of BDR. 
ACE analysis indicated that genetic and shared environ-
mental effects were modest and that they together ex-
plained about one-third of total variance in FEV1 change 
(A:15%, C: 18%), while unshared environmental influence 
explained the largest part of variance (E: 67%) (Table 3). In 
the ACE model, sex and baseline FEV1 were significantly as-
sociated with FEV1 change, while age, BMI, and smoking 
history were not significantly associated (data not shown).
DISCuSSIon
Although the assessment of bronchodilator response has 
become routine in clinical practice, background of the 
large variation of BDR in asymptomatic persons has re-
mained unclear. BDR response is a common, but not a spe-
cific measure of bronchial asthma, which has considerable 
prevalence among non-asthmatic persons (28). We found 
that BDR was weakly influenced by genetic factors and 
shared environment, and strongly influenced by unshared 
environmental factors. This result might clarify the large 
standard deviation of BDR responses in asymptomatic per-
sons without airways disease. The finding that unshared 
environmental component mainly explains the variation 
also suggests the importance of prevention (eg, smoking 
prevention in persons with high-risk for asthma/COPD or 
lifestyle modification). Accordingly, our results highlight 
that lifestyle factors have an important role in the determi-
nation of BDR test results in individuals without lung dis-
eases, so these factors should be eliminated before BDR 
assessment and be taken into account in the interpreta-
tion of the results.
Genetic influences have been investigated in diseases re-
lated to pathologic BDR. For example, heritability of asth-
ma has been widely demonstrated (29-34). Although the 
current twin study is the first study investigating BDR, nu-
merous workgroups examined airway hyperresponsive-
ness, another common characteristic of asthma (13-18). 
Hopp et al suggested the role of hereditary influences on 
airway hyperresponsiveness to methacholine by sim-
ply estimating the MZ and DZ correlations for twin 
TABLE 2. Multiple regression analysis of FEV1 (forced exhaled volume in one second) % change and considered covariates. Full 
model*
FEV1% change Coefficient Standard error P 95% confidence interval
Sex (males vs females) -0.567 0.239 0.018 -1.036, -0.099
Age -0.151 0.095 0.110 -0.336, 0.034
Baseline FEV1 -0.317 0.126 0.012 -0.563, -0.069
Smoking habits†
past smokers -0.179 0.226 0.428 -0.622, 0.264
current smokers -0.187 0.204 0.360 -0.589, 0.214
Body mass index -0.06 0.089 0.477 -0.239, 0.111
*All continuous variables were standardized to have zero mean and a standard deviation of 1 prior to estimating the regression equation.
†reference category: never smokers.
TABLE 3. Within pair correlations and genetic and environmental variance components of FEV1 (forced exhaled volume in one sec-
ond) % change as estimated under the ACE model (A – heritability; C – shared environment; E – unshared environment). numbers in 
parentheses indicate 95% confidence intervals*†
Twin correlation Proportions (%) of variance components
Measure rMZ rDZ A C E
FEV1% change 0.332 (0.083, 0.532) 0.258 (-0.041, 0.499) 14.9 (0, 53.1) 18.4 (0, 46.8) 66.8 (46.8, 88.7)
*FEV1 – forced exhaled volume in one second; rMZ – correlation in monozygotic twins; rDZ – correlation in dizygotic twins.
†Intraclass correlations and variance components were adjusted for age and sex and baseline FEV1.
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pairs (6-31 years) (15). They also reported that increased 
non-specific bronchial reactivity was persistent and asso-
ciated with allergy (14). Zamel et al demonstrated in ten 
MZ and ten DZ healthy, nonsmoking twins the major role 
of environmental factors in determining the variability 
of acute AHR to bronchoactive drugs (18). An Australian 
twin study in 381 twin pairs aged 8 to 18 years suggest-
ed that hereditary effects may be largely shared between 
asthma, atopy, and AHR (13). Lund et al reported no heri-
tability for AHR in younger adult twins (age 18-31 years) 
(16) and that shared environmental factors explained 30% 
of the AHR variance (16). These factors may include diet, 
exposure to high levels of air pollution, parental smoking 
and other conditions in the parental home, such as house 
dust mites, mold, etc. Compared to their results, we found 
a weak hereditary component for BDR (15%) and a simi-
lar (67%) unshared environmental component. Unshared 
environmental factors may include differences in diseases 
and occupational exposures. This is supported by a previ-
ous study reporting a relationship between bronchial hy-
perresponsiveness and infections after the neonatal pe-
riod in school-aged twins (35). Apart from twin studies, 
there is evidence from familial aggregation studies, seg-
regation analyses, linkage studies, and genome-wide link-
age analyses of hereditary influence on BDR, suggesting 
that interactions between genes and environmental com-
ponents may also be involved (13,15,36-40).
Smoking status is an important environmental factor to be 
examined. Although smoking increases the risk of airway 
responsiveness (36), Lund et al in their heritability analy-
sis did not analyze the effect of smoking (16). In the pres-
ent study, the twin sample comprised 32.9% active or ex-
smokers. Although the association of smoking with AHR is 
well known (41), we did not observe a significant role of 
smoking status on BDR; however, this may be explained 
by the relatively low rate of active smokers (17.3%). Ac-
cordingly, the effect of smoking on the ACE models was 
not assessed. The lack of relationship between smoking 
status and BDR is not surprising, as a study conducted in 
a large cohort of patients with obstructive airway disease 
showed that BDR was related to smoking history rather 
than to current smoking status (19). However, we could 
not completely eliminate the possible effects of smoking 
on ACE modeling by stratifying the quantitative genetic 
analyses according to pair-wise smoking status and an-
alyzing the non-smokers only. This limitation should be 
considered in future larger twin studies investigating the 
effect of smoking on the heritability of BDR. Structural 
equation modeling has decreased power to assess 
models (for genetic vs shared environmental vs unique 
environmental components) when the genetic effect is 
low (less than ~ 20%) (42). This also prevented the explora-
tion of sex differences in the heritability and environmen-
tal effects on BDR.
The main strength of the present study is that all BDR tests 
were performed by the same trained researchers and the 
same validated device at all sites. Furthermore, the results 
can be generalized to the non-twin adult population, as-
suming that the enrolled twins did not differ from non-
twin individuals with regard to the considered traits.
In conclusion, the present study revealed a low heritability 
of BDR independently of sex, age, and baseline FEV
1 in a 
healthy twin population. Unshared environmental effects 
explained most of the BDR variance, underscoring the im-
portance of environmental factors (eg, lifestyle, allergens) 
in determining individual differences in BDR in healthy 
adult individuals. This finding might explain the frequently 
experienced large standard deviation of BDR assessments 
in asymptomatic persons without airways disease, empha-
sizing the importance of lifestyle factors that influence BDR 
test results.
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